InsidersTradesSigma
Tango Therapeutics, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the Tango Therapeutics, Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Market capitalisation: €4.4bn. The latest transaction was reported on 5 August 2026 (Levée d'options). Among the most active insiders: Third Rock Ventures IV, L.P.. All data is openly available.
94
Insider Decl.
n/a
Thresholds
€13m
6 ops.
Buy Volume
€67m
41 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Tango Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$44.33.
39Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 August 2026
Declarations94 total
27,000 shares@ US$5.20Common StockSEC:0001193125-26-335002:0
5,267 shares@ US$26.7895Common StockSEC:0001193125-26-335002:1
21,733 shares@ US$27.3509Common StockSEC:0001193125-26-335002:2
81,000 shares@ US$27.180.050% mcap100.0% of flowCommonSEC144:0001950047-26-007562
5,740 sharesCommon StockSEC:0001193125-26-279871:0
3,766,081 shares@ US$30.102.26% mcap100.0% of flowCommon StockSEC144:0001894038-26-000002
1,791,726 shares@ US$28.75641.02% mcap100.0% of flowCommonSEC144:0001950047-26-005968
4,446 shares@ US$30.000.0029% mcap0.3% of flowCommonSEC144:0001950047-26-005901
4,000 shares0Common StockSEC:0001193125-26-262205:0
38,460 shares@ US$5.200.0040% mcap15.2% of flowCommon StockSEC:0001193125-26-159747:0
38,460 shares@ US$25.000.019% mcap73.0% of flowCommon StockSEC:0001193125-26-159747:1
27,000 shares@ US$5.207.0% of flowCommon StockSEC:0001193125-26-140874:0
27,000 shares@ US$21.202928.6% of flowCommon StockSEC:0001193125-26-140874:1
12,000 shares@ US$5.203.0% of flowCommon StockSEC:0001193125-26-129990:0
20,251 shares@ US$15.009.9% of flowCommon StockSEC:0001193125-26-098443:0
54,345 shares@ US$12.774122.4% of flowCommon StockSEC:0001193125-26-083579:0
44,330 shares0Common StockSEC:0001193125-26-038072:0
37,522 shares0Common StockSEC:0001193125-26-038070:0
47,460 shares0Common StockSEC:0001193125-26-038052:0
350,000 shares0Common StockSEC:0001193125-26-009663:0
477,401 shares@ US$10.15210.2% of flowCommon StockSEC:0001193125-25-251606:0
500,000 shares@ US$8.0179.4% of flowCommon StockSEC:0001193125-25-223227:0
363,541 shares@ US$7.046.5% of flowCommon StockSEC:0001193125-25-206453:0
25 of 94 declarations
About Tango Therapeutics, Inc.
Tango Therapeutics, Inc. is a biopharmaceutical company focused on developing targeted therapies for cancer treatment. It employs innovative approaches to identify and exploit the genetic vulnerabilities of tumor cells.